Mirati Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
N/A
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-8.37

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.47-5.71-8.27-1.13-6.54-13.31-22.70-27.64-13.08-3.43-2.97-6.54
Price/Sales ratio
N/AN/AN/AN/AN/A101.391.44K737.50105.56204.87177.16101.39
Price/Book Value ratio
7.108.894.511.943.226.5012.627.265.442.552.216.50
Price/Cash Flow ratio
-6.24-7.62-10.53-1.38-7.13-18.69-32.68-36.39-19.57-4.46-3.86-7.13
Price/Free Cash Flow ratio
-6.19-7.53-10.46-1.37-7.12-18.66-32.34-35.81-19.09-4.42-3.82-7.12
Price/Earnings Growth ratio
-0.020.17-0.46-0.110.19-0.92-0.29-0.69-0.31-0.190.170.17
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/A-626.22%-5383.23%-2134.28%-605.47%95.17%2.68%2.68%
Operating Profit Margin
N/AN/AN/AN/AN/A-793.95%-6659.79%-2756.85%-795.06%-6107.98%-6107.98%-793.95%
Pretax Profit Margin
N/AN/AN/AN/AN/A-761.39%-6394.48%-2671.57%-802.42%-5953.35%-5953.35%-761.39%
Net Profit Margin
N/AN/AN/AN/AN/A-761.39%-6374.72%-2667.75%-807.00%-5957.43%-5957.43%-761.39%
Effective Tax Rate
0.04%-0.27%0.38%0.18%0.18%-4.27%0.30%0.14%-0.57%-0.06%-0.06%-4.27%
Return on Assets
-81.92%-130.48%-50.38%-131.04%-44.82%-43.08%-49.18%-24.21%-36.61%-61.60%-61.60%-43.08%
Return On Equity
-204.25%-155.66%-54.58%-172.10%-49.19%-48.82%-55.61%-26.26%-41.64%-74.34%-66.04%-48.82%
Return on Capital Employed
-123.49%-139.24%-54.74%-172.94%-49.81%-50.72%-57.94%-26.29%-39.66%-72.81%-72.81%-50.72%
Liquidity Ratios
Current Ratio
12.246.0512.793.9611.418.668.6719.63N/AN/A6.958.66
Quick Ratio
1.646.2112.823.9811.438.698.7119.6710.516.936.808.69
Cash ratio
0.365.4312.483.7811.058.528.4819.442.871.471.478.52
Days of Sales Outstanding
N/AN/AN/AN/AN/A21.68171.39N/AN/A25.3825.3821.68
Days of Inventory outstanding
N/AN/AN/A-0.97-1.48-2.98-3.12-2.80-1.801.83K1.83K-1.48
Operating Cycle
N/AN/AN/AN/AN/A18.70168.26-2.80-1.801.86K1.84K1.84K
Days of Payables Outstanding
N/AN/AN/A79.9585.73100.2295.9722.0925.2323.64K23.64K85.73
Cash Conversion Cycle
N/AN/AN/AN/AN/A-81.5172.29-24.89-27.03-21.77K-23.16K-81.51
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.000.17N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.000.20N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.00N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-72.73N/AN/A
Company Equity Multiplier
2.491.191.081.311.091.131.131.081.131.201.201.09
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/A-5.42-44.29-20.26-5.39-45.88-45.88-5.42
Free Cash Flow / Operating Cash Flow Ratio
1.001.011.001.001.001.001.011.011.021.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-72.73N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-72.73N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A